Bluejay Diagnostics (BJDX) Selling, General & Administrative (2020 - 2026)
Bluejay Diagnostics (BJDX) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 3.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.28 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.06 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.78 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 522.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 349.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -207.22 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 1.12 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Bluejay Diagnostics | 2,754.24 | 2,754.24 | - | 1.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.13 Mn |
| Dec 31, 2025 | 875,603.00 |
| Sep 30, 2025 | 831,339.00 |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 929,831.00 |
| Sep 30, 2024 | 809,199.00 |
| Jun 30, 2024 | 862,482.00 |
| Mar 31, 2024 | 1.09 Mn |
| Dec 31, 2023 | 1.10 Mn |
| Sep 30, 2023 | 963,534.00 |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | 148,046.00 |
| Dec 31, 2022 | 961,888.00 |
| Sep 30, 2022 | 146,102.00 |
| Jun 30, 2022 | 1.20 Mn |
| Mar 31, 2022 | 1.32 Mn |
| Dec 31, 2021 | 817,691.00 |
| Sep 30, 2021 | 445,050.00 |
| Jun 30, 2021 | 389,830.00 |